# Agilent Technologies Inc. (NYSE: A) Q3 2025 Financial Results Summary
**Release date:** August 27, 2025
Agilent Technologies Inc. reported strong financial results for the third quarter of fiscal year 2025, ending July 31, 2025, highlighting a significant increase in revenue and earnings compared to the same quarter last year. Below is a summary of the key financial metrics and developments reported:
### Key Financial Results
– **Revenue:**
– Reached **$1.74 billion**, exceeding revenue guidance.
– Represented **10.1% growth** (reported) and **6.1% growth** (core) compared to Q3 2024.
– **Net Income:**
– **GAAP net income:** **$336 million**, up from **$282 million** a year ago, reflecting a **19.2% increase**.
– **Earnings per share (EPS):**
– GAAP EPS of **$1.18** vs. **$0.97** in Q3 2024, representing a **21.6% increase**.
– Non-GAAP EPS of **$1.37**, a **3.8% increase** from **$1.32** in Q3 2024.
### Segment Performance
– **Life Sciences and Diagnostics Markets Group (LDG):**
– Revenue of **$670 million**, up **14%** year-over-year.
– Operating margin of **17.6%**.
– **Agilent CrossLab Group (ACG):**
– Revenue of **$744 million**, representing an **8% increase** year-over-year.
– Operating margin of **33.3%**.
– **Applied Markets Group (AMG):**
– Revenue of **$324 million**, up **7%** year-over-year.
– Operating margin at **21.8%**.
### Financial Guidance
– **Full-Year 2025 Revenue Outlook:**
– Revised to a range of **$6.91 billion to $6.93 billion**, which indicates **6.2% to 6.5%** reported growth and **4.3% to 4.6%** core growth.
– Non-GAAP EPS forecasted to range from **$5.56 to $5.59**.
– **Q4 Revenue Outlook:**
– Expected to range between **$1.822 billion to $1.842 billion**, reflecting growth of **7.1% to 8.3%** reported and **4.8% to 6.0% core**.
– Non-GAAP EPS estimated between **$1.57 and $1.60** per share.
### Shareholder Returns
– The company declared quarterly dividends of **$212 million**, which marks an increase from **$206 million** paid in the same quarter of the previous year.
– Additionally, Agilent repurchased **$340 million** of its common stock during the quarter.
### Other Financial Metrics
– **Total Assets:**
– Increased to **$12.226 billion** from **$11.846 billion** the prior year.
– **Total Liabilities:**
– Stand at **$5.856 billion**, a decrease from **$5.948 billion** in the prior year.
– **Stockholders’ Equity:**
– Increased to **$6.370 billion** from **$5.898 billion** reported in the previous year.
### Conclusion
Agilent Technologies has reported positive financial results for Q3 2025. The figures indicate solid revenue and net income growth compared to Q3 2024, alongside strategic initiatives to return value to shareholders through dividends and stock repurchases. The company remains focused on its innovative growth strategies and has adjusted its outlook for the remainder of the fiscal year.
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| July 31, 2025 | 2024 | July 31, 2025 | 2024 | |
| Net revenue | $1,738 | $1,578 | $5,087 | $4,809 |
| Costs and expenses: | ||||
| Cost of products and services | $850 | $723 | $2,434 | $2,190 |
| Research and development | $111 | $127 | $336 | $368 |
| Selling, general and administrative | $417 | $395 | $1,281 | $1,171 |
| Total costs and expenses | $1,378 | $1,245 | $4,051 | $3,729 |
| Income from operations | $360 | $333 | $1,036 | $1,080 |
| Interest income | $16 | $19 | $45 | $56 |
| Interest expense | -$28 | -$22 | -$85 | -$64 |
| Other income (expense), net | $18 | $13 | -$3 | $48 |
| Income before taxes | $366 | $343 | $993 | $1,120 |
| Provision for income taxes | $30 | $61 | $124 | $182 |
| Net income | $336 | $282 | $869 | $938 |
| Net income per share: | ||||
| Basic | $1.18 | $0.97 | $3.05 | $3.21 |
| Diluted | $1.18 | $0.97 | $3.05 | $3.20 |
| Weighted average shares used in computing net income per share: | ||||
| Basic | 284 | 290 | 285 | 292 |
| Diluted | 285 | 291 | 285 | 293 |
The preliminary income statement is estimated based on our current information.
| July 31, 2025 | October 31, 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $1,535 | $1,329 |
| Accounts receivable, net | $1,382 | $1,324 |
| Inventory | $1,014 | $972 |
| Other current assets | $322 | $334 |
| Total current assets | $4,253 | $3,959 |
| Property, plant and equipment, net | $1,966 | $1,778 |
| Goodwill | $4,475 | $4,477 |
| Other intangible assets, net | $469 | $547 |
| Long-term investments | $133 | $175 |
| Other assets | $930 | $910 |
| Total assets | $12,226 | $11,846 |
| LIABILITIES AND EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $530 | $540 |
| Employee compensation and benefits | $346 | $368 |
| Deferred revenue | $620 | $544 |
| Short-term debt | $59 | $45 |
| Other accrued liabilities | $337 | $398 |
| Total current liabilities | $1,892 | $1,895 |
| Long-term debt | $3,350 | $3,345 |
| Retirement and post-retirement benefits | $119 | $130 |
| Other long-term liabilities | $495 | $578 |
| Total liabilities | $5,856 | $5,948 |
| Total Equity: | ||
| Stockholders’ equity: | ||
| Preferred stock; $0.01 par value; | — | — |
| 125,000,000 shares authorized; none | — | — |
| issued and outstanding | ||
| Common stock; $0.01 par value; | ||
| 2,000,000,000 shares authorized; | ||
| 283,593,838 shares at July 31, 2025 and | 3 | |
| 285,193,011 shares at October 31, 2024, | ||
| issued and outstanding | ||
| Additional paid-in-capital | $5,548 | $5,450 |
| Retained earnings | $1,102 | $750 |
| Accumulated other comprehensive loss | -$283 | -$305 |
| Total stockholders’ equity | $6,370 | $5,898 |
| Total liabilities and stockholders’ | $12,226 | $11,846 |
| equity |
The preliminary balance sheet is estimated based on our current information.
